PDB Short entry for 2L87 HEADER SIGNALING PROTEIN 06-JAN-11 2L87 TITLE THE 27-RESIDUE N-TERMINUS CCR5-PEPTIDE IN A TERNARY COMPLEX WITH HIV-1 TITLE 2 GP120 AND A CD4-MIMIC PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-C CHEMOKINE RECEPTOR TYPE 5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, RESIDUES 1-27; COMPND 5 SYNONYM: CCR5, C-C CKR-5, CC-CKR-5, CCR5, CHEMR13, HIV-1 FUSION COMPND 6 CORECEPTOR; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: CHEMICAL SYNTHESIS KEYWDS HELIX, HIV CO-RECEPTOR, SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR E.SCHNUR,E.NOAH,I.AYZENSHTAT,H.SARGSYAN,T.INUI,F.X.DING,B.ARSHAVA, AUTHOR 2 Y.SAGI,N.KESSLER,R.LEVY,T.SCHERF,F.NAIDER,J.ANGLISTER REVDAT 2 14-JUN-23 2L87 1 SEQADV LINK REVDAT 1 27-JUL-11 2L87 0 JRNL AUTH E.SCHNUR,E.NOAH,I.AYZENSHTAT,H.SARGSYAN,T.INUI,F.X.DING, JRNL AUTH 2 B.ARSHAVA,Y.SAGI,N.KESSLER,R.LEVY,T.SCHERF,F.NAIDER, JRNL AUTH 3 J.ANGLISTER JRNL TITL THE CONFORMATION AND ORIENTATION OF A 27-RESIDUE CCR5 JRNL TITL 2 PEPTIDE IN A TERNARY COMPLEX WITH HIV-1 GP120 AND A JRNL TITL 3 CD4-MIMIC PEPTIDE. JRNL REF J.MOL.BIOL. V. 410 778 2011 JRNL REFN ISSN 0022-2836 JRNL PMID 21763489 JRNL DOI 10.1016/J.JMB.2011.04.023 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRVIEW, CNS REMARK 3 AUTHORS : JOHNSON, ONE MOON SCIENTIFIC (NMRVIEW), REMARK 3 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI, REMARK 3 NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L87 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000102078. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 300 REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 1MM NT-CCR5; 0.1MM REMARK 210 GP120/CD4MIMIC; 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 TYR A 3 REMARK 465 GLN A 4 REMARK 465 VAL A 5 REMARK 465 SER A 6 REMARK 465 ASN A 24 REMARK 465 VAL A 25 REMARK 465 LYS A 26 REMARK 465 GLN A 27 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 8 28.39 -78.74 REMARK 500 1 PRO A 19 43.65 -71.66 REMARK 500 2 PRO A 8 25.16 -63.22 REMARK 500 2 PRO A 19 48.17 -78.30 REMARK 500 3 PRO A 8 29.18 -79.24 REMARK 500 3 SER A 17 -97.24 -46.96 REMARK 500 3 PRO A 19 32.31 -77.69 REMARK 500 4 PRO A 8 25.61 -63.48 REMARK 500 4 PRO A 19 44.57 -72.44 REMARK 500 5 PRO A 19 42.15 -70.81 REMARK 500 6 PRO A 19 45.68 -70.25 REMARK 500 7 PRO A 8 9.24 -68.81 REMARK 500 7 PRO A 19 40.72 -74.65 REMARK 500 8 PRO A 8 30.27 -76.35 REMARK 500 8 PRO A 19 43.56 -72.16 REMARK 500 9 PRO A 8 -125.83 -89.66 REMARK 500 9 ILE A 9 -6.80 -53.73 REMARK 500 9 ASN A 13 21.56 -76.78 REMARK 500 9 TYS A 14 -9.76 -59.61 REMARK 500 9 PRO A 19 41.88 -68.62 REMARK 500 10 PRO A 8 26.79 -76.33 REMARK 500 10 SER A 17 -91.35 -51.45 REMARK 500 10 PRO A 19 37.26 -74.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17395 RELATED DB: BMRB DBREF 2L87 A 1 27 UNP P51681 CCR5_HUMAN 1 27 SEQADV 2L87 ALA A 20 UNP P51681 CYS 20 ENGINEERED MUTATION SEQRES 1 A 27 MET ASP TYR GLN VAL SER SER PRO ILE TYS ASP ILE ASN SEQRES 2 A 27 TYS TYR THR SER GLU PRO ALA GLN LYS ILE ASN VAL LYS SEQRES 3 A 27 GLN MODRES 2L87 TYS A 10 TYR O-SULFO-L-TYROSINE MODRES 2L87 TYS A 14 TYR O-SULFO-L-TYROSINE HET TYS A 10 24 HET TYS A 14 24 HETNAM TYS O-SULFO-L-TYROSINE FORMUL 1 TYS 2(C9 H11 N O6 S) HELIX 1 1 ILE A 9 ILE A 12 5 4 HELIX 2 2 ASN A 13 GLU A 18 1 6 LINK C TYS A 10 N ASP A 11 1555 1555 1.33 LINK C TYS A 14 N TYR A 15 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000